PHASE GENOMICS, INC.

Seattle, WA · Founded 2015 · CIK 0001722760 · Medtech

Hi-C-based proximity ligation sequencing platform for detecting chromosomal aberrations in formalin-fixed paraffin-embedded (FFPE) tumor tissue

phasegenomics.com →
Grants
$18M
20 awards
Sector median: 1
Raised
$5.8M
2 Form D · Mar 2023
43 months since last filing
Contracts
—
No federal contracts on record
Patents
11
1 granted · 10 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Deconvolution and Assembly of Metgenomes Using Chromatin Conformation Capture$216,192
Private capital raisedForm D · SEC$1,000,001
Federal grantDepartment of Health and Human Services · Phase II · Deconvolution and Assembly of Metagenomes Using Chromatin Conformation Capture$1,499,644
Federal grantDepartment of Health and Human Services · Phase II · Deconvolution and Assembly of Metagenomes Using Chromatin Conformation Capture$749,394
Federal grantDepartment of Health and Human Services · Phase II · A proximity ligation method to track mobile element hosts$1,494,834
Federal grantDepartment of Health and Human Services · Phase II · A next-generation method for cytogenomics using Hi-C proximity ligation sequencing$249,984
Federal grantDepartment of Health and Human Services · Phase I · Next generation cytogenomics using proximity ligation sequencing$249,984
Federal grantDepartment of Health and Human Services · Phase II · A proximity ligation method to track mobile element hosts$895,817
Federal grantDepartment of Health and Human Services · Phase II · A method for the culture-free discovery and host affiliation of novel viruses from metagenomic samples$1,640,758
Federal grantDepartment of Agriculture · Strain-level Diagnostics Of Fungal Crop Pathogens Enabled By Fully-phased Isolate Genomes$99,866
Federal grantDepartment of Health and Human Services · Phase II · A next-generation method for cytogenomics using Hi-C proximity ligation sequencing$1,675,858
Federal grantDepartment of Health and Human Services · Phase II · A method for the culture-free discovery and host affiliation of novel viruses from metagenomic samples$820,379
Federal grantDepartment of Health and Human Services · Phase II · A next-generation method for cytogenomics using Hi-C proximity ligation sequencing$837,867
Federal grantDepartment of Health and Human Services · Phase II · Therapeutic phage host-range prediction using proximity-guided metagenomics and artificial intelligence$1,991,746
Private capital raisedForm D · SEC$4,754,364
Federal grantDepartment of Health and Human Services · Phase II · Therapeutic phage host-range prediction using proximity-guided metagenomics and artificial intelligence$995,873
Federal grantDepartment of Health and Human Services · Phase I · Biological validation of phage host-range identified by proximity guided metagenomics$299,132
Federal grantDepartment of Health and Human Services · Phase II · AI-based AML risk stratification using next generation cytogenomics$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Chromosomal aberration detection in FFPE tissue using proximity ligation sequencing$858,324
Federal grantDepartment of Health and Human Services · Phase II · AI-based AML risk stratification using next generation cytogenomics$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Chromosomal aberration detection in FFPE tissue using proximity ligation sequencing$1,141,676
Federal grantDepartment of Health and Human Services · Phase I · Harnessing mRNA Vaccine Technology for Precision Antimicrobial Delivery$299,163
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1150Valisure—$9.8M
1151Envision Genomics—$160K
1152Vivifi Medical LLC——
1153PHASE GENOMICS, INC.—$5.8M
1154CorVent Medical, Inc.—$13M
1155Ischemia Care, LLC—$11M
1156EarliTec Diagnostics, Inc.—$30M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Ivan LiachkoDirector · Executive Officer · Promoter
  • Shawn SullivanExecutive Officer · Promoter
  • Kayla YoungExecutive Officer

Patents

USPTO · 1 granted of 11
  • Method For The Clustering Of Dna Sequencesapplication
  • A Method For The Clustering Of Dna Sequencesgranted
  • Chromosome Conformation Capture From Tissue Samplesapplication
  • Systems And Methods For Karyotyping By Sequencingapplication
  • Chomosome Conformation Capture From Tissue Samplesapplication
  • Systems And Methods For Karyotyping By Sequencingapplication
  • A Method For The Clustering Of Dna Sequencesapplication
  • Lysins For Treatment Of Bacterial Infectionapplication
  • Method For The Clustering Of Dna Sequencesapplication
  • Lysins For Treatment Of Bacterial Infectionapplication
  • Chomosome Conformation Capture From Tissue Samplesapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.